 |
|
 |
 |

Home > Company Index > Drugs > Drug Manufacturers - Major > Sankyo Co., Ltd.
 |
Sankyo Co., Ltd. |
 |
 |
 |
PROFILE |
 |
Sankyo is Japan's second-largest pharmaceutical company (behind Takeda Chemical Industries). The company's stable of drugs includes antibiotics, diabetes medications, and neurological agents. Cholesterol treatment Mevalotin accounts for about half of its sales. Sankyo develops its drugs through an extensive independent network of laboratories in Europe, South America, and the US. In addition to prescription pharmaceuticals, the company makes OTC medications, veterinary drugs, food ingredients, and agricultural chemicals. Diabetes drug Noscal (Rezulin in the US, where it is marketed by Pfizer) has been removed from several markets because of safety concerns; the company has discontinued its production.
COMPETITION |
 |
Aventis (AVE)
Merck & Co., Inc. (MRK)
Takeda Chemical Industries, Ltd. (4502)
|
 |
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: March
2000 Sales (mil.): 5,589.50
1-Yr. Sales Growth: 8.2%
Employees: 6,622
Revenue per employee: $844,080.34
KEY PEOPLE |
 |
Tetsuo Takato
CEO
Susumu Kawabe
CFO
CONTACT INFO |
 |
5-1 Nihonbashi-Honcho 3-chome
Tokyo 103-8426, Japan
Phone: 81-3-5255-7111
Fax: 81-3-5255-7035
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |